Mr Hutchins will be responsible for leading the company's global business development and reinforcing WuXi's brand value and market leadership. Mr Hutchins will report directly to Ge Li, chairman and CEO of WuXi PharmaTech.
Prior to joining WuXi PharmaTech, Mr Hutchins was vice president of business development and collaboration management at BioDuro, a US-based life science outsourcing service company and earlier senior director of global basic and preclinical sourcing at Merck.
Mr Hutchins has received his BS in chemistry from University of New Hampshire, New Hampshire.
Ge Li said: "I am very pleased to welcome Steven on board. Steven's intimate knowledge of Contract Research Organizations and deep understanding of pharmaceutical R&D outsourcing needs will help WuXi to continue the strong business growth."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index